Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending May 27
BMW of North America, WeWork, Sonoco, Harrods, Athenahealth, TPI Composites, Covanta, MeridianLink, Physicians Resources LTD, MindMed
By
Lauren Muskett
| May 27, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Christophe Weber
Strategy
Shire Accepts Improved $62B Bid From Takeda
The deal is the largest-ever by a Japanese company and gives Takeda a lucrative portfolio of rare disease drugs.
By
Matthew Heller
| May 8, 2018
Read More
Strategy
Takeda Buys Ariad in $5.2B Cancer Drug Bet
The Japanese drug giant is paying a 75% premium for Ariad to "transform our global solid tumor franchise."
By
Matthew Heller
| January 10, 2017
Read More